Nunavut Deschedules Naloxone and Allows Remote Pharmacist Supervision

Nunavut's Department of Health announced interim changes to pharmacy practice in the territory on October 31, 2025, as temporary measures while a full regulatory framework under the 2025 Pharmacy Professions Act is finalized, targeted for late 2026.

Key takeaways

• Naloxone nasal spray and injection were removed from the controlled substances list under the Pharmacy Act, making the opioid-overdose reversal drug available directly to the public rather than only through controlled channels.
• Pharmacists can now remotely supervise Nunavut pharmacies under certain conditions, addressing chronic pharmacist-coverage gaps in a territory with only three regional pharmacies -- in Iqaluit, Rankin Inlet and Cambridge Bay -- serving 25 communities.
• Nurse practitioners were newly authorized to prescribe medications.
• The Department of Health framed the goal as "improving access to medicine" ahead of permanent regulations that will also cover professional standards, pharmacy technician registration, supervision and misconduct processes.

Why this matters

Nunavut has no independent college of pharmacists, unlike the provinces; pharmacists in the territory are governed by the Department of Health's own Professional Practice Unit, per the National Association of Pharmacy Regulatory Authorities (NAPRA). With only three regional pharmacies covering the entire territory, staffing gaps can leave communities without in-person pharmacist coverage -- remote supervision is a direct, practical response to that geography, and descheduling naloxone removes a control-access barrier to a drug used specifically to save lives in an overdose emergency.

Practice guidance for pharmacists

• Pharmacists providing remote supervision for a Nunavut pharmacy should confirm exactly which conditions and documentation the interim rule requires, since the framework is still temporary pending the full regulations.
• Community pharmacies and outreach programs in the North should update any patient-facing materials that still describe naloxone as requiring special authorization to obtain.
• Nurse practitioners and pharmacists working alongside each other in Nunavut should clarify prescribing responsibilities now that NPs have new prescribing authority under the same interim framework.
• Watch for the permanent regulatory framework expected in late 2026, which will additionally cover pharmacy technician registration and misconduct processes not addressed by these interim changes.

What's next

Nunavut's Department of Health is targeting late 2026 for a full regulatory framework under the 2025 Pharmacy Professions Act, which will formalize professional standards, technician registration, supervision requirements and misconduct processes beyond the interim measures described here.